Join us to hear one of the most respected leaders in the genomics space, Dr. Jill Hagenkord share her thoughts on U… 
LATEST NEWS
October 1, 2020
19 Organizations from the Healthcare Community Unite to Form COVID-19 Testing Industry Consortium
Widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect needed to limit the spread of the disease. By creating...
Read More
October 1, 2020
Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials
Sema4, a patient-centered health intelligence company, today announced that it has entered into a research agreement with Janssen Research & Development, LLC (Janssen) to...
Read More
October 1, 2020
Ionis and Genuity Science announce agreement designed to rapidly translate genomic insights into therapeutics
Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration...
Read More
October 1, 2020
Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions
LC-SCRUM-Asia, a leading cancer genomic screening program, has selected Thermo Fisher Scientific’s Ion Torrent Genexus System* and Oncomine Precision Assay*, a pan-cancer panel, to...
Read More
September 10, 2020
Bristol Myers Squibb Research at ESMO Virtual Congress 2020 Highlights Significant Progress in Cancers with High Unmet Medical Need
Bristol Myers Squibb (NYSE:BMY) today announced the presentation of research spanning 15 different cancers at the upcoming European Society for Medical Oncology (ESMO) Virtual...
Read More
September 10, 2020
AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020
AstraZeneca will present new developments in pursuit of its ambition to eliminate cancer as a cause of death at the European Society for Medical...
Read More
